Post-approval studies (Phase 4)UnknownNCT01105611
What this trial is testing
Safety and Efficacy Study Comparing Raltegravir to a Protease Inhibitor in Treatment-naïve, HIV/Hepatitis C Drug Users
Who this might be right for
HIV InfectionsHepatitis C
St. James's Hospital, Ireland 40